BCG vaccination: historical role, modern applications, and future perspectives in tuberculosis and beyond
Frontiers in Pediatrics · 31.07.2025 · 13
DOI: 10.3389/fped.2025.1603732 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pediatrics, online erschienen am 31.07.2025. Verfasst von Anna Starshinova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics and Computer Science, Saint Petersburg State University, St. Petersburg, Russia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tuberculosis (TB) remains a fatal disease primarily transmitted through airborne droplets, with children who are the most susceptible, particularly in the areas with poor tuberculosis control. The BCG vaccine, developed by Albert Calmette and Camille Guérin, has a history spanning a century. This vaccine has been implemented in numerous countries, significantly reducing child mortality in regions heavily affected by TB. In this review, we aim to revisit the vaccine's development and rollout, while also highlighting its current attributes and the successful application in the Russian Federation, where 90% of newborns receive the anti-tuberculosis vaccination. Due to that practice, only a few isolated cases of young children with generalized tuberculosis (about five to seven annually) are observed in Russia. Research on the BCG vaccine is ongoing, revealing significant genetic alterations in BCG strains that have evolved from the original variant. These genetic differences may contribute to variations in vaccine efficacy, making screening important to predict effectiveness. The BCG vaccine can initiate a localized mucosal immune response, offering, besides the anti-TB effect, some protection against infections involving mucous membranes, including salmonellosis, HIV, and acute viral respiratory infections. It is essential to investigate the role of BCG in various applications; however, this exploration should not detract from its main protective benefits against tuberculosis (TB). Future studies may provide evidence of the vaccine's safety and efficacy to support its use beyond TB prevention. While BCG vaccination does not lower the risk of infection with Mycobacterium tuberculosis , it does prevent the progression to the most severe clinical manifestations (such as miliary TB and tuberculous meningitis) caused by hematogenous spread of M.tuberculosis . The challenge of protecting HIV-infected children from TB remains urgent, especially in regions burdened with drug-resistant TB, highlighting the need for robust protective measures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mathematics and Computer Science, Saint Petersburg State University, St. Petersburg, Russia.
- Medical Department, Saint Petersburg State University, St. Petersburg, Russia.
- Medical Department, Almazov National Medical Research Centre, Saint-Petersburg, Russia.
- Department of Immunology, Institution of Experimental Medicine, St. Petersburg, Russia.
- Phthisiopulmonology Department, Research Institute of Phthisiopulmonology, St. Petersburg, Russia.
- Department of Pharmacology, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Zitieren
APA
Starshinova, A., Kudryavtsev, I., Rubinstein, A., Dovgalyuk, I., Kulpina, A., Churilov, L. P., & Kudlay, D. (2025). BCG vaccination: historical role, modern applications, and future perspectives in tuberculosis and beyond. Frontiers in Pediatrics, 13. https://doi.org/10.3389/fped.2025.1603732
Vancouver
Starshinova A, Kudryavtsev I, Rubinstein A, Dovgalyuk I, Kulpina A, Churilov LP, et al. BCG vaccination: historical role, modern applications, and future perspectives in tuberculosis and beyond. Frontiers in Pediatrics. 2025;13. doi:10.3389/fped.2025.1603732
BibTeX
@article{Starshinova2025,
author = {Starshinova, Anna and Kudryavtsev, Igor and Rubinstein, Artem and Dovgalyuk, Irina and Kulpina, Anastasia and Churilov, Leonid P and Kudlay, Dmitry},
title = {BCG vaccination: historical role, modern applications, and future perspectives in tuberculosis and beyond},
journal = {Frontiers in Pediatrics},
year = {2025},
volume = {13},
doi = {10.3389/fped.2025.1603732}
}
EUVIMED